Remus Pharmaceuticals Limited IPO (Remus Pharmaceuticals IPO) Detail

May 17, 2023 - May 19, 2023

Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.

The product offerings of the company can be classified into two major categories:

  • APIs: Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
  • Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms.

The product portfolio consists of 429 products, as on January 31, 2023. They operate under different brand names across the globe. As on January 31, 2023, the company has 295 products registered in a total of 13 countries. As on January 31, 2023, a total of 134 ;products are under the process of registration in 16 countries.

As on January 31, 2023, Remus Pharmaceuticals had business-to-business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.

The company has cultivated strong and dependable customer relationships and its clients are spread in more than 20 countries. These clients range from Generic distributors, regional distributors, and Multinational distributors to Hospitals and Clinics.

Remus Pharmaceuticals IPO Details

IPO Date May 17, 2023 to May 19, 2023
Listing Date May 29, 2023
Face Value ₹10 per share
Price ₹1150 to ₹1229 per share
Lot Size 100 Shares
Total Issue Size388,000 shares
(aggregating up to ₹47.69 Cr)
Fresh Issue388,000 shares
(aggregating up to ₹47.69 Cr)
Issue Type Book Built Issue IPO
Listing At NSE SME
Share holding pre issue1,085,000
Share holding post issue1,473,000
Market Maker portion19,500 shares (Sunflower Broking)

Remus Pharmaceuticals IPO Reservation

QIB Shares Offered138,750 (35.76%)
NII (HNI) Shares Offered41,625 (10.73%)
Retail Shares Offered97,125 (25.03%)
Anchor Investor Shares Offered110,500 (28.48%)
Total Shares Offered277,500
Total Shares With Anchor Investor388,000

Remus Pharmaceuticals IPO Timetable (Tentative)

Remus Pharmaceuticals IPO opens on May 17, 2023, and closes on May 19, 2023.

Event Tentative Date
Opening Date Wednesday, 17 May 2023
Closing Date Friday, 19 May 2023
Basis of Allotment Wednesday, 24 May 2023
Initiation of Refunds Thursday, 25 May 2023
Credit of Shares to Demat Friday, 26 May 2023
Listing Date Monday, 29 May 2023
Cut-off time for UPI mandate confirmation 5 PM on May 19, 2023

Remus Pharmaceuticals IPO Lot Size

The Remus Pharmaceuticals IPO lot size is 100 shares.

Application Lots Shares Amount
Retail (Min) 1 100 ₹122,900
Retail (Max) 1 100 ₹122,900
HNI (Min) 2 200 ₹245,800
Lot Size Calculator

Remus Pharmaceuticals IPO Promoter Holding

Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah, and Mrs. Anar Swapnil Shah are the Promoters of the company.

Pre Issue Share Holding 92.82%
Post Issue Share Holding 68.37%

Company Financials

Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
Amount in ₹ Lakhs

Key Performance Indicator

KPI Values
P/E (x)21.09
Market Cap (₹ Cr.)181.03
EPS (Rs)33.86
RoNW (%)52.64

Objects of the Issue

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:

  1. To Meet Working Capital Requirements
  2. Funding investments for acquisitions and general corporate purposes
  3. To meet Public Issue Expenses

Remus Pharmaceuticals IPO Review (Avoid)

[Dilip Davda]  The company is in a highly competitive and fragmented segment of pharma product distribution with third-party contracts under the B2B model. Its profit margins are non-convincing. Based on super profits the issue appears fully priced. The sustainability of margins is a major concern. There is no harm in skipping this tricky issue that will have a longer gestation period for migration to the main board as post IPO its paid-up equity capital is just under Rs. 1.5 cr. Read detail review...

Remus Pharmaceuticals IPO Subscription Status (Bidding Detail)

The Remus Pharmaceuticals IPO is subscribed 57.21 times on May 19, 2023 7:29:00 PM. The public issue subscribed 49.81 times in the retail category, 10.75 times in the QIB category, and 229.31 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Total Application : 48,376 (49.77 times)

Remus Pharmaceuticals IPO Prospectus

Remus Pharmaceuticals IPO Rating

Rating:Rated 3.5 stars
Vote Here ...

Remus Pharmaceuticals IPO Listing Details

Listing Date May 29, 2023
BSE Script Code
Final Issue Price ₹1229 per share

Pre-Open Session - NSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Company Contact Information

Remus Pharmaceuticals Limited
1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli bopal Road, Ahmedabad - 380054
Phone: +079- 2999 9857
Email: cs@remuspharma.com
Website: http://www.remuspharma.com/

Remus Pharmaceuticals IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: remuspharmaceuticals.ipo@linkintime.co.in
Website: https://linkintime.co.in/

Remus Pharmaceuticals IPO Analysis

Remus Pharmaceuticals IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 0 0 1
Members 2 1 2

Read All Reviews Post Your Review Manage Reviews

SME IPO Enquiry

SME Company Owners
We could help you get listed on the stock market.

Contact us Today

Check our SME IPO Guide New

Remus Pharmaceuticals IPO FAQs

Remus Pharmaceuticals IPO is a SME IPO of 388,000 equity shares of the face value of ₹10 aggregating up to ₹47.69 Crores. The issue is priced at ₹1150 to ₹1229 per share. The minimum order quantity is 100 Shares.

The IPO opens on May 17, 2023, and closes on May 19, 2023.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Remus Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Remus Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Remus Pharmaceuticals IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Remus Pharmaceuticals IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Remus Pharmaceuticals IPO opens on May 17, 2023 and closes on May 19, 2023.

Remus Pharmaceuticals IPO lot size is 100 Shares and the minimum order quantity is .

You can apply in Remus Pharmaceuticals IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Remus Pharmaceuticals IPO will be done on Wednesday, 24 May 2023, and the allotted shares will be credited to your demat account by Friday, 26 May 2023. Check the Remus Pharmaceuticals IPO allotment status.

The Remus Pharmaceuticals IPO listing date is on May 29, 2023.
Open an Instant Account with Zerodha

Remus Pharmaceuticals IPO Message Board

Ranked Members of Chittorgarh.com Forum  Ranked Members | Most Liked Members